ConductScience.org, home

Trial · NCT07085169

Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC

NCT07085169, Phase 2, Recruiting, Ruijin Hospital

3 sourcestrials-2026-11-12-0.4.0

Download JSON
Cite this record

ConductScience Library. Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC. Trials, record NCT07085169. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07085169

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC
NCT number
NCT07085169
Status
Recruiting
Phases
Phase 2
Enrollment
50 participants, estimated
Lead sponsor
Ruijin Hospital
Conditions
Colo-rectal Cancer, Third-line and Beyond Therapy, TAS 102, Bevacizumab
Interventions
Trifluridine/tipiracil (TAS-102) plus bevacizumab
First posted
2025-07-25
Last updated
2025-07-25

Source ClinicalTrials.gov

Registered outcomes5

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
Primary6-month progression-free survival rate6 monthsDefined as the proportion of patients who remain free from disease progression (as per RECIST criteria) or death for at least 6 months following initiation of study treatment.
SecondaryAdverse eventsthrough study completion, an average of 1 year
SecondaryObjective response rateup to 16 weeks
SecondaryProgression free survivalFrom date of enrollment until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 60 months
SecondaryOverall survivalFrom date of enrollment until the date of death from any cause, assessed up to 100 months

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Source

Release
trials-2026-11-12-0.4.0
Release manifest SHA-256
0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
Registry capture
2026-11-12
Results copy, AACT
2026-03-23
NIH clinical studies file
2026-11-13

Source ClinicalTrials.gov

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07085169

GET https://conductscience.org/api/trials/v1/NCT07085169/registered